January 10th 2025
The co-leaders of the financing were Novo Holdings and Bpifrance, with other investments from Invus, UI Investissement, Seroba Life Sciences, Fund+, Kurma Partners, Omnes Capital, and Turenne Capital.
SGS Opens New Clinical Research Site in Belgium and Expands Biosafety Testing Capacity in UK
October 28th 2021SGS’s new Antwerp, Belgium, clinical research site will house both clinical trial patients and good manufacturing practice drug manufacturing, and its Glasgow, UK, biosafety testing site now has increased testing capacity.
NIIMBL Receives Federal Funding for Biopharmaceutical Manufacturing Projects
July 16th 2021The US federal government awarded new funding to the National Institute for Innovation in Manufacturing Biopharmaceuticals, including funding under the American Rescue Plan that will be used to advance vaccine manufacturing.
Thermo Fisher Scientific Expands Sterile Drug Product Development and Commercial Manufacturing
December 9th 2020The company is investing in expansion at four sites in the United States, United Kingdom, and Italy, which will include construction of new facilities and addition of sterile and lyophilized filling lines.